Making strides in ophthalmology with modern gene therapy techniques

Promising gene therapies in development are pinpointing steps in the pathogenic cascades involved in ocular diseases, such as VEGF for wet AMD and CFI for dry AMD.

Weekly review in ophthalmology: 7 May - 13 May

An end-of-week review of what happened in ophthalmology from 7 May to 13 May.

Promising early data with intravitreal diabetic macular ischaemia candidate

An ischaemia modulator has demonstrated it is safe and well tolerated in a Phase 1/2a trial in diabetic macular ischaemia patients.

Testing spectacle lenses for myopia control in relation to changes in axial length

May 04, 2022

Dr Eva Chamorro points out that myopia control spectacle lenses affect the diurnal rhythms in the AL in young adult human and produced a small short-term increase in the AL that varies in intensity and time interval for each of the 3 studied lenses.

Predicting metastasis with novel prognostic liquid biopsy for uveal melanoma

May 04, 2022

Investigators from the Karolinska Institutet and St. Erik Eye Hospital, Stockholm, Sweden, reported that they have developed a prognostic test, referred to as serUM, that they believe is a strong predictor of metastasis of uveal melanoma.

Relationship between dry eye disease and high myopia in teenagers investigated in study

May 03, 2022

In a poster presented at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting, Dr Osama Ibrahim Hirayama and colleagues offered results that demonstrating that anisometropia and astigmatic error were greater among the patients with high myopia compared with the other groups. Compared with the subjects with no myopia, those with high myopia reported significantly more dryness, less photophobia, and less pain.